Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2013 043 910.9 |
96 | EP file number | EAKZ | 13 75 9908.0 |
86 | WO file number | WAKZ | PCT/US2013/055747 |
97 | EP publication number | EPN | 2888281 |
87 | WO publication number | WPN | 2014031610 |
54 | Designation/title | TI | VERFAHREN ZUR BEHANDLUNG ODER VERHINDERUNG VON ASTHMA DURCH VERABREICHUNG EINES IL-4R-ANTAGONISTEN |
51 | IPC main class | ICM (ICMV) | C07K 16/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/395 (2006.01), C12Q 1/68 (2018.01) |
22 | DE application date | DAT | Aug 20, 2013 |
96 | EP application date | EAT | Aug 20, 2013 |
86 | WO application date | WAT | Aug 20, 2013 |
43 | Date of first publication | OT | Feb 27, 2014 |
| Date of publication of grant | PET | Sep 19, 2018 |
71/73 | Applicant/owner | INH | Regeneron Pharmaceuticals, Inc., Tarrytown, N.Y., US; Sanofi Biotechnology, Paris, FR |
72 | Inventor | IN | ARDELEANU, Marius, Tarrytown, New York 10591-6707, US; GANDHI, Namita, Tarrytown, New York 10591-6707, US; GRAHAM, Neil, Tarrytown, New York 10591-6707, US; KIRKESSELI, Stephane, C., Bridgewater, New Jersey 08807, US; KUNDU, Sudeep, Bridgewater, New Jersey 08807, US; RADIN, Allen, Tarrytown, New York 10591-6707, US; ROCKLIN, Ross, E., Bridgewater, New Jersey 08807, US; WEINSTEIN, Steven, Tarrytown, New York 10591-6707, US; DAVIDSON HAMILTON, Jennifer, Tarrytown, New York 10591-6707, US; MING, Jeffrey, Bridgewater, New Jersey 08807, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| FR 1356994 Jul 16, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261691625 P Aug 21, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361758097 P Jan 29, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361805797 P Mar 27, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361761279 P Feb 6, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361783796 P Mar 14, 2013
|
| Due date | FT FG | Aug 31, 2025 Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002888281 Searchable text:
EP000002888281 Original document:
EP000002888281B1 Searchable text:
EP000002888281B1 Original document:
WO002014031610 Searchable text:
WO002014031610 |
43 | Date of first publication | EVT | Feb 27, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Jul 2, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 10, 2024 (Show all update days)(Hide all update days)- Sep 10, 2024
- St.36: changed (technical change)
- Jul 4, 2024; Jul 1, 2023; Jun 22, 2022; Jul 22, 2021; Aug 11, 2020; Sep 10, 2019; Aug 14, 2019; Aug 8, 2019; Mar 7, 2019; Dec 14, 2018; Oct 11, 2018; Sep 11, 2018; Sep 6, 2018; Feb 15, 2018; Aug 14, 2015
- Historical data not available for this/these date(s)
- Jul 2, 2015
- Date of the first transfer into DPMAregister
|